Prealbumin Prognostic Score: A Novel Prognostic Indicator After Radical Gastrectomy in Patients with Gastric Cancer
- Ryota Matsui 1, Souya Nunobe 1, Motonari Ri 1, Rie Makuuchi 1, Tomoyuki Irino 1, Masaru Hayami 1, Manabu Ohashi 1, Takeshi Sano 1
- Ryota Matsui 1, Souya Nunobe 1, Motonari Ri 1
- 1Department of Gastroenterological Surgery, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.
- 0Department of Gastroenterological Surgery, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The novel prealbumin prognostic score (PPS) better predicts overall survival in gastric cancer patients post-surgery than the modified Glasgow Prognostic Score (mGPS). This new score, using prealbumin and CRP, identifies more patients with poor outcomes after gastrectomy.
Area Of Science
- Oncology
- Surgical Gastroenterology
- Biomarker Research
Background
- Gastric cancer prognosis is often assessed using inflammatory markers.
- The modified Glasgow Prognostic Score (mGPS) uses albumin and C-reactive protein (CRP).
- Prealbumin may offer a more sensitive indicator of nutritional status and inflammation.
Purpose Of The Study
- To evaluate the prealbumin prognostic score (PPS) as a predictive marker in gastric cancer patients.
- To compare the efficacy of PPS against the established mGPS post-gastrectomy.
- To determine if PPS improves the identification of patients with poor overall survival (OS).
Main Methods
- Retrospective analysis of 4663 patients undergoing radical gastrectomy for Stages I-III gastric cancer (2006-2017).
- Preoperative prealbumin (cutoff 22 mg/dL) and CRP (cutoff 0.5 mg/dL) levels were used to calculate PPS.
- PPS categories: 0 (both markers above cutoff), 1 (one marker below cutoff), 2 (both markers below cutoff).
Main Results
- Higher PPS correlated significantly with poorer overall survival (OS) (p < 0.001).
- PPS of one indicated poorer OS than PPS of zero, even in patients with mGPS of zero (p < 0.001).
- Multivariate analysis identified PPS 1 (HR 1.603) and PPS 2 (HR 1.322) as independent poor prognostic factors for OS.
Conclusions
- The prealbumin prognostic score (PPS) effectively predicts overall survival in gastric cancer patients post-gastrectomy.
- PPS demonstrates superior ability to identify a broader range of patients with poor OS compared to mGPS.
- PPS, combining prealbumin and CRP, offers a valuable tool for prognostic assessment in gastric cancer management.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

